ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MT..RS......................*JDIM360 Ver 2.15 (14 Jul 2008) - 2999001/02086939CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120110622W173deBibliographieenBibliographyfrBibliographieEP07824375.5200710312009060320090804enenen864303 P20061103US864247 P20061103US2011062220112520090812200933201007282010302010012520110622201125C07D 213/82 20060101AFI20090603BHEP C07D 401/04 20060101ALI20090603BHEP C07D 401/12 20060101ALI20090603BHEP C07D 401/14 20060101ALI20090603BHEP C07D 413/04 20060101ALI20090603BHEP A61K 31/44 20060101ALI20090603BHEP A61K 31/444 20060101ALI20090603BHEP A61K 31/4439 20060101ALI20090603BHEP dePYRIDINCARBOXAMIDE ALS 11-BETA-HSD1-INHIBITORENenPYRIDINE CARBOXAMIDES AS 11-BETA-HSD1 INHIBITORSfrCARBOXAMIDES DE PYRIDINE EN TANT QU'INHIBITEURS DE L'11-BETA-HSD1WO-A-2004/065351WO-A-2004/089896WO-A-2005/054200WO-A-2008/012532BARF T ET AL: "Recent progress in 11-[beta]-hydroxysteroid dehydrogenase type 1 (11-[beta]-HSD1) inhibitor development" DRUGS OF THE FUTURE, BARCELONA, ES, vol. 31, no. 3, 1 March 2006 (2006-03-01), pages 231-243, XP002424785 ISSN: 0377-828210163730.4223348020100525MCCOULL, WilliamAstraZeneca R & D Alderley Alderley Park MacclesfieldCheshire SK10 4TGGBPACKER, MartinAstraZeneca R & D Alderley Alderley Park MacclesfieldCheshire SK10 4TGGBSCOTT, James StewartAstraZeneca R & D Alderley Alderley Park MacclesfieldCheshire SK10 4TGGBWHITTAMORE, Paul Robert OwenAstraZeneca R & D Alderley Alderley Park MacclesfieldCheshire SK10 4TGGBAstraZeneca AB100826879102522-1X EP/CV151 85 SödertäljeSEATBEBGCHCYCZDEDKEEESFIFRGBGRHUIEISITLILTLULVMCMTNLPLPTROSESISKTRAL20090603BA20090603HR20090603MK20090603RS20090603GB200700413120071031enWO200805319420080508200819